Another anti-fibrotic drug, pirfenidone (PFD), can also inhibit collagen synthesis by antagonizing TGF-β signaling, significantly suppressing the growth and metastasis of breast cancer cells when combined with chemotherapy [236]. The gene discussed is TGFB1; the disease is breast carcinoma.